Blackstone Inc’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.75M | Sell |
178,546
-5,201
| -3% | -$226K | 0.03% | 88 |
|
2025
Q1 | $6.86M | Buy |
183,747
+103,747
| +130% | +$3.88M | 0.03% | 89 |
|
2024
Q4 | $3.62M | Hold |
80,000
| – | – | 0.02% | 99 |
|
2024
Q3 | $4.7M | Hold |
80,000
| – | – | 0.02% | 94 |
|
2024
Q2 | $3.15M | Sell |
80,000
-150,000
| -65% | -$5.9M | 0.01% | 104 |
|
2024
Q1 | $15.3M | Sell |
230,000
-121,810
| -35% | -$8.09M | 0.06% | 73 |
|
2023
Q4 | $9.83M | Buy |
351,810
+52,688
| +18% | +$1.47M | 0.04% | 67 |
|
2023
Q3 | $6.37M | Buy |
+299,122
| New | +$6.37M | 0.03% | 89 |
|